haloperidol has been researched along with a 68930 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerman, M; Artman, L; Asin, KE; Bednarz, L; Briggs, C; Britton, DR; DeNinno, MP; MacKenzie, R; Schoenleber, R; Trugman, JM | 1 |
| Gronier, B; Ponten, H; Waters, S | 1 |
2 other study(ies) available for haloperidol and a 68930
| Article | Year |
|---|---|
A68930: a potent agonist selective for the dopamine D1 receptor.
Topics: Adenylyl Cyclases; Animals; Benzazepines; Binding Sites; Carps; Chromans; Deoxyglucose; Dopamine Agents; Haloperidol; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D1; Seizures; Substantia Nigra; Tumor Cells, Cultured | 1991 |
The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex.
Topics: Animals; Benzazepines; Chromans; Data Interpretation, Statistical; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiological Phenomena; Haloperidol; Injections, Intravenous; Male; Neurons; Piperidines; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2013 |